The Congenital Hyperinsulinism Market is witnessing strong growth as awareness of rare endocrine disorders improves and advancements in diagnostic and therapeutic approaches continue worldwide. Congenital hyperinsulinism (CHI) is a rare genetic condition characterized by inappropriate and excessive insulin secretion, leading to persistent hypoglycemia, particularly in newborns and inf... https://www.databridgemarketresearch.com/reports/global-congenital-hyperinsulinism-market